Tag Archives: Adicet Bio

First Analysis Downgrades Adicet Bio (ACET) to Hold

In a report issued on November 14, First Analysis from First Analysis downgraded Adicet Bio (ACET – Research Report) to Hold. The company’s shares closed last Friday at $13.52, close to its 52-week low of $6.02. Adicet Bio has an

First Analysis Thinks Adicet Bio’s Stock is Going to Recover

First Analysis analyst First Analysis initiated coverage with a Buy rating on Adicet Bio (ACET – Research Report) on March 31. The company’s shares closed last Friday at $13.52, close to its 52-week low of $6.02. Adicet Bio has an

Analysts Offer Insights on Healthcare Companies: Adicet Bio (NASDAQ: ACET) and Durect (NASDAQ: DRRX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Adicet Bio (ACET – Research Report) and Durect (DRRX – Research Report) with bullish sentiments. Durect (DRRX) B.Riley Financial analyst Mayank Mamtani